DE69419246D1 - Zusammensetzungen zur oralen verabreichung von peptiden - Google Patents

Zusammensetzungen zur oralen verabreichung von peptiden

Info

Publication number
DE69419246D1
DE69419246D1 DE69419246T DE69419246T DE69419246D1 DE 69419246 D1 DE69419246 D1 DE 69419246D1 DE 69419246 T DE69419246 T DE 69419246T DE 69419246 T DE69419246 T DE 69419246T DE 69419246 D1 DE69419246 D1 DE 69419246D1
Authority
DE
Germany
Prior art keywords
pct
oral administration
spheres
date sep
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69419246T
Other languages
English (en)
Other versions
DE69419246T2 (de
Inventor
Anne Fjellestad-Paulsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FJELLESTAD PAULSEN ANNE
Original Assignee
FJELLESTAD PAULSEN ANNE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FJELLESTAD PAULSEN ANNE filed Critical FJELLESTAD PAULSEN ANNE
Publication of DE69419246D1 publication Critical patent/DE69419246D1/de
Application granted granted Critical
Publication of DE69419246T2 publication Critical patent/DE69419246T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69419246T 1993-03-19 1994-03-18 Zusammensetzungen zur oralen verabreichung von peptiden Expired - Fee Related DE69419246T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9300937A SE9300937L (sv) 1993-03-19 1993-03-19 Komposition för oral administrering av peptider
PCT/SE1994/000244 WO1994021286A1 (en) 1993-03-19 1994-03-18 Composition for oral administration of peptides

Publications (2)

Publication Number Publication Date
DE69419246D1 true DE69419246D1 (de) 1999-07-29
DE69419246T2 DE69419246T2 (de) 2000-01-20

Family

ID=20389308

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69419246T Expired - Fee Related DE69419246T2 (de) 1993-03-19 1994-03-18 Zusammensetzungen zur oralen verabreichung von peptiden

Country Status (10)

Country Link
US (1) US5780434A (de)
EP (1) EP0689452B1 (de)
AT (1) ATE181508T1 (de)
AU (1) AU6388994A (de)
DE (1) DE69419246T2 (de)
DK (1) DK0689452T3 (de)
ES (1) ES2135570T3 (de)
GR (1) GR3031312T3 (de)
SE (1) SE9300937L (de)
WO (1) WO1994021286A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
EP1335938B1 (de) 2000-11-10 2010-09-22 F. Hoffmann-La Roche Ltd. Apolipoprotein-Konstrukte
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
EP1530967B1 (de) * 2003-11-13 2006-05-03 Ferring B.V. Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
CN101107013A (zh) 2004-11-22 2008-01-16 阿纳迪斯有限公司 生物活性组合物
DE602006012513D1 (de) * 2005-08-26 2010-04-08 Healthpartners Res Foundation Verfahren zur behandlung von kopfschmerzen durch verabreichung von oxytocin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
ES2596435T3 (es) * 2008-05-21 2017-01-09 Ferring B.V. Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nicturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
AU2010260211B2 (en) 2008-12-22 2016-04-21 Acerus Pharmaceuticals USA, LLC Safe desmopressin administration
MX2017008913A (es) 2015-01-07 2018-04-30 Trigemina Inc Formulaciones de oxitocina que contienen magnesio y metodos de uso.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139504A (en) * 1977-06-16 1979-02-13 Coy David Howard Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
JPS608225A (ja) * 1983-06-29 1985-01-17 Kowa Co 腸管吸収医薬組成物
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
WO1989007110A1 (en) * 1988-01-28 1989-08-10 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
DE3919982A1 (de) * 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform
JP3009911B2 (ja) * 1989-06-28 2000-02-14 エーザイ株式会社 ペプチド又は蛋白の内服用新規製剤
JPH04364131A (ja) * 1991-04-03 1992-12-16 Sanwa Kagaku Kenkyusho Co Ltd 易吸収性モチリン製剤
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments

Also Published As

Publication number Publication date
ES2135570T3 (es) 1999-11-01
DE69419246T2 (de) 2000-01-20
ATE181508T1 (de) 1999-07-15
US5780434A (en) 1998-07-14
WO1994021286A1 (en) 1994-09-29
GR3031312T3 (en) 1999-12-31
SE9300937D0 (sv) 1993-03-19
AU6388994A (en) 1994-10-11
DK0689452T3 (da) 1999-12-13
EP0689452B1 (de) 1999-06-23
EP0689452A1 (de) 1996-01-03
SE9300937L (sv) 1994-09-20

Similar Documents

Publication Publication Date Title
DE69517801D1 (de) Stabilisierte zusammensetzung zur oralen verabreichung von peptiden
DE69419246D1 (de) Zusammensetzungen zur oralen verabreichung von peptiden
KR100197465B1 (en) Rapidly disintegratable multiparticulate tablet
EP0225189A3 (en) Targeted enteral delivery system
EP1275381A4 (de) Feste überzogene zubereitungen mit zeitabhängiger freisetzung zur oralen verabreichung
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
ES2365648T3 (es) Administración oral de una calcitonina.
SK169999A3 (en) Controlled release pharmaceutical preparation with ace inhibitor as active agent
RU2449796C9 (ru) Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
CN100508957C (zh) 肽经口输递的改进
ZA901945B (en) Therapeutic agents
EP0817643A4 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee